Quantum Cyber N.V. Investing Cash Flow
Quantum Cyber N.V. (QUCY) reported Investing Cash Flow of $262.54 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-14
- Quantum Cyber N.V. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $913.20K.
- Quantum Cyber N.V. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$650.66K.
- Quantum Cyber N.V. net cash provided by (used in) investing activities for the quarter ending 2025-06-30 was -$250.00K.
- Quantum Cyber N.V. net cash provided by (used in) investing activities for the quarter ending 2025-03-31 was -$198.04K.
- Quantum Cyber N.V. net cash provided by (used in) investing activities for fiscal 2025 was -$1.03M.
- Quantum Cyber N.V. net cash provided by (used in) investing activities for fiscal 2024 was -$198.82K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|
| 2026-06-30 | $913.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $262.54K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$650.66K 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | -$1.03M 10-K · filed 2026-03-31 | ||
| 2025-06-30 | -$250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$448.04K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | -$198.04K 10-Q · filed 2026-05-15 | ||
| 2024-12-31 | -$198.82K 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |